Key result
Oral disopyramide restores sinus rhythm in ~54% of supraventricular arrhythmia patients with minimal hemodynamic complications.
Why the study?
Does oral disopyramide safely induce reversion to sinus rhythm in patients with supraventricular cardiac arrhythmias?
Does oral disopyramide safely induce reversion to sinus rhythm in patients with supraventricular cardiac arrhythmias?
Oral disopyramide appears to be an effective and safe antiarrhythmic drug for reverting supraventricular cardiac arrhythmias to sinus rhythm.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for oral disopyramide in supraventricular arrhythmias; prospective randomized trials needed before clinical adoption.
Disopyramide was given orally to 35 patients with supraventricular cardiac arrhythmias. All but one of the 19 patients who reverted to sinus rhythm did so without any major haemodynamic complication. Disopyramide appeared to be an effective and safe antiarrhythmic drug.
No takes yet. Share an insight, caveat, or question.
Sloman et al. (1977) studied this question. Oral disopyramide restored sinus rhythm in 19 of 35 patients with supraventricular arrhythmias, with 18 of those 19 experiencing no major hemodynamic complications.
Synapse has enriched 10 related papers. Consider them for comparative context: